Bradley Foster & Sargent Inc Novo Nordisk A S Transaction History
Bradley Foster & Sargent Inc
- $5.77 Billion
- Q4 2024
A detailed history of Bradley Foster & Sargent Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 57,764 shares of NVO stock, worth $4.44 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
57,764
Previous 59,486
2.89%
Holding current value
$4.44 Million
Previous $7.08 Million
29.85%
% of portfolio
0.09%
Previous 0.12%
Shares
25 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.53 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.19 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$999 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$972 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$938 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $173B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...